Introduction to small molecule drug discovery and preclinical development
Over 90% of marketed drugs are small molecules, low molecular weight organic compounds that have been discovered, designed, and developed to prompt a specific biological process in the body. Examples include antibiotics (penicillin), analgesics (paracetamol) and synthetic hormones (corticosteroids)....
Main Authors: | Michelle W. Y. Southey, Michael Brunavs |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Drug Discovery |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fddsv.2023.1314077/full |
Similar Items
-
Drug discovery and development: introduction to the general public and patient groups
by: Natesh Singh, et al.
Published: (2023-05-01) -
Post-Pandemic Drug Discovery and Development: Facing Present and Future Challenges
by: Bruno O. Villoutreix
Published: (2021-07-01) -
Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8
by: Shravan Morla, et al.
Published: (2020-08-01) -
Mechanisms of Action for Small Molecules Revealed by Structural Biology in Drug Discovery
by: Qingxin Li, et al.
Published: (2020-07-01) -
RNA-targeted small-molecule drug discoveries: a machine-learning perspective
by: Huan Xiao, et al.
Published: (2023-12-01)